Why A Bristol-Myers Squibb Bid On Celgene Is Plausible By: Benzinga via Benzinga April 24, 2015 at 13:31 PM EDT Bristol-Myers Squibb Co (NYSE: BMY)'s rumored interest in acquiring Celgene Corp. (NASDAQ: CELG) sounds plausible, an analyst ... Read More >> Related Stocks: Bristol-Myers Squibb Celgene Corp